These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2500885)

  • 1. [Treatment of growth hormone deficiencies by GHRH].
    Rochiccioli P; Tauber M
    Ann Pediatr (Paris); 1989 May; 36(5):293-7. PubMed ID: 2500885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth hormone-releasing hormone: therapeutic perspectives.
    Gelato MC; Malozowski S; Pescovitz OH; Cassorla F; Loriaux DL; Merriam GR
    Pediatrician; 1987; 14(3):162-7. PubMed ID: 3134651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acceleration of growth rate in growth hormone-deficient children treated with human growth hormone-releasing hormone.
    Thorner MO; Rogol AD; Blizzard RM; Klingensmith GJ; Najjar J; Misra R; Burr I; Chao G; Martha P; Mcdonald J
    Pediatr Res; 1988 Aug; 24(2):145-51. PubMed ID: 3141891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth hormone releasing hormone. Review].
    Rosskamp R
    Klin Padiatr; 1988; 200(2):81-8. PubMed ID: 3133522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of GH-releasing hormone and biosynthetic GH in a group of children with growth hormone deficiency].
    Biscaldi I; Fiori A; Moretta A; Valtorta A
    Medicina (Firenze); 1990; 10(2):145-6. PubMed ID: 2273946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GHRH and GH secretagogues: clinical perspectives and safety.
    Aimaretti G; Baldelli R; Corneli G; Bellone S; Rovere S; Croce C; Ragazzoni F; Giordano R; Arvat E; Bona G; Ghigo E
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():86-92. PubMed ID: 16456487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Growth hormone-releasing hormone (GHRH) as a diagnostic and therapeutic agent].
    Oostdijk W
    Tijdschr Kindergeneeskd; 1988 May; 56 Suppl 1():24-6. PubMed ID: 3137695
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating non-22 kDa growth hormone isoforms after a repeated GHRH stimulus in normal subjects.
    Coya R; Algorta J; Boguszewski CL; Vela A; Carlsson LM; Aniel-Quiroga A; Busturia MA; Martul P
    Growth Horm IGF Res; 2005 Apr; 15(2):123-9. PubMed ID: 15809015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nocturnal pulsatile growth hormone releasing hormone treatment in growth hormone deficiency.
    Smith PJ; Brook CG; Rivier J; Vale W; Thorner MO
    Clin Endocrinol (Oxf); 1986 Jul; 25(1):35-44. PubMed ID: 3098459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The therapeutic use of growth-hormone-releasing hormone.
    Low LC
    J Pediatr Endocrinol; 1993; 6(1):15-20. PubMed ID: 8374684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous GHRH(1-29)NH2 promotes growth over 1 year in short, slowly growing children.
    Brain CE; Hindmarsh PC; Brook CG
    Clin Endocrinol (Oxf); 1990 Feb; 32(2):153-63. PubMed ID: 2140733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone releasing hormone or growth hormone treatment in growth hormone insufficiency?
    Smith PJ; Brook CG
    Arch Dis Child; 1988 Jun; 63(6):629-34. PubMed ID: 2898924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in prepubertal growth hormone deficient children. Venezuelan Collaborative Study Group.
    Lanes R; Carrillo E
    J Pediatr Endocrinol; 1994; 7(4):303-8. PubMed ID: 7735367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of continuous subcutaneous growth hormone-releasing hormone (GHRH (1-29)NH2) infusions to augment growth hormone secretion and to promote growth.
    Brain C; Hindmarsh PC; Pringle PJ; Brook CG
    Acta Paediatr Scand Suppl; 1989; 349():109-13; discussion 123-4. PubMed ID: 2546369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Growth hormone-releasing factor (GRF) in the treatment of the child with a growth hormone (GH) deficiency].
    Lanes R
    An Esp Pediatr; 1992 Jun; 36 Suppl 48():169-71. PubMed ID: 1636959
    [No Abstract]   [Full Text] [Related]  

  • 16. Repetitive injections of GHRH in normal children and adults.
    Sartorio A; Conti A; Spada A; Faglia G
    Horm Metab Res; 1990 Sep; 22(9):510. PubMed ID: 2258141
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of children with slow growth: how much of what for whom?].
    Wit JM
    Ned Tijdschr Geneeskd; 1990 May; 134(18):899-904. PubMed ID: 2111882
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of growth hormone deficiencies with growth hormone releasing hormone. Current status and perspectives].
    Auzerie J; Colle M; Guinot P; Lavergne V
    Arch Pediatr; 1995 Apr; 2(4):365-72. PubMed ID: 7780546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic [D-Ala2]-growth hormone-releasing hormone administration attenuates age-related deficits in spatial memory.
    Thornton PL; Ingram RL; Sonntag WE
    J Gerontol A Biol Sci Med Sci; 2000 Feb; 55(2):B106-12. PubMed ID: 10737685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical value of neuropeptides GHRH and GHRP].
    Savage MO; Korbonits M; Grossman AB
    Arch Pediatr; 1996; 3 Suppl 1():148s-150s. PubMed ID: 8795997
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.